Project Grant P01MH139137
- The National Institute of Mental Health awarded $3.161 million to the University of Texas Health Science Center at Houston on July 1, 2026, under the Mental Health Research Grants program (CFDA 93.242) to study care coordination between hospitals and specialty behavioral health clinics for adults with serious mental illness. The research uses Medicaid administrative claims from multiple states and a quasi-experimental approach to assess whether implementation of the Certified Community...
- The National Institute of Mental Health awarded Indiana University Indianapolis $1.632 million on August 12, 2026, under the Mental Health Research Grants program (CFDA 93.242) to establish and operate Academic-Community EPINET, a learning healthcare system network designed to enhance outcomes in early psychosis care through improved stress tolerance and continuous quality improvement. The award funds a network of six early intervention clinical spoke sites connected through advanced informatics...
- The National Institute of Mental Health awarded the University of Texas Health Science Center at Houston $777,176 on August 1, 2026, under the Mental Health Research Grants program (CFDA 93.242) to develop and test biomarker-supported prevention intervention for schizophrenia spectrum disorder in at-risk children. The project will recruit children aged 9 to 18 with significant family history of schizophrenia spectrum disorder and other modifiable risk factors but without subclinical or...
- The National Institute of Mental Health awarded The University of Texas Southwestern Medical Center $793,864 on September 1, 2026, under the Mental Health Research Grants program (CFDA 93.242) to investigate the neuronal mechanisms of control learning using human single unit recording. The research examines how frontal and medial temporal brain regions coordinate to support cognitive control and how disruptions in this coordination contribute to psychiatric illnesses. UT Southwestern will...
- The National Institute of Mental Health awarded the University of Texas at Austin $3,093,180 on July 1, 2026 under the Mental Health Research Grants program (CFDA 93.242) to investigate synaptic plasticity mechanisms that protect and refine local circuits in the brain. The research focuses on how synapse structure supports learning and memory, with specific emphasis on dendritic spines—small protrusions hosting most excitatory synapses in the brain. The project employs three-dimensional...
- Federal Project Grant Award Summary The University of Texas at Arlington received a $769,753 Project Grant from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242), awarded July 21, 2025, with completion targeted for April 30, 2030. This research initiative aims to identify neural biomarkers and biotypes underlying posttraumatic stress disorder (PTSD), major depressive disorder (MDD), and anxiety disorders (ANXs) by leveraging...
- The National Institute of Mental Health awarded the University of Texas at Austin $439,250 on July 15, 2026, under the Mental Health Research Grants program (CFDA 93.242) to investigate the causal role of the amygdala in emotional memory processes using transcranial focused ultrasound neuromodulation. The research tests whether direct modulation of amygdala activity with low-intensity transcranial focused ultrasound affects explicit memory processes in healthy adult volunteers, employing a...
- Federal Grant Award Summary The National Institute of Mental Health (NIMH) awarded $913,000 in Project Grant funding (CFDA 93.242: Mental Health Research Grants) to the University of Texas Southwestern Medical Center, effective September 1, 2025, through August 31, 2027. The research project, titled "Social Media Concerns Related to Emotional Experience in Naturalistic Settings: SCREENS," responds to RFA-MH-25-206 (Bidirectional Influences Between Adolescent Social Media Use and Mental...
- The National Institute of Mental Health awarded the University of Texas at Austin $234,504 on August 20, 2026, under the Mental Health Research Grants program (CFDA 93.242) to conduct research on contextual modulation of fear and extinction using immersive virtual reality. The research investigates how emotional and environmental contexts shape threat acquisition and extinction learning in humans, with the aim of informing strategies to enhance anxiety disorder treatment efficacy and reduce...
- The National Institute of Mental Health awarded Texas A&M University System Health Science Center $559,215 on August 1, 2026, under the Mental Health Research Grants program (CFDA 93.242) to fund research on the function of astrocytic NMDA receptors in behavioral control and drug responses. The funded research examines how astrocytes—active participants in synaptic function—express non-canonical NMDA receptors and their role in regulating neurotransmission, synapse organization, and...
The National Institute of Mental Health awarded the University of Texas at Austin $1.633 million on September 1, 2026, under the Mental Health Research Grants program (CFDA 93.242) to establish and operate an administrative research core supporting the Early Psychosis Intervention Network in Texas (EPINET-TX), a learning health system focused on coordinated specialty care for individuals experiencing early psychosis. The award funds development of standardized data collection systems, data-driven decision-making infrastructure, measurement-based care protocols, participatory action research methods, and quality improvement processes across 15 community mental health coordinated specialty care sites in Texas. The core will leverage data collected through EPINET-TX's core assessment battery to examine the impact of social connection and belonging on symptom and functioning outcomes among individuals receiving coordinated specialty care. EPINET-TX, established in 2020 as a partnership between the University of Texas at Austin and 15 community mental health CSC sites, has previously delivered system-level and program-level improvements through standardized data collection, published research, workforce trainings, and tool development addressing early psychosis practice and outcomes. Performance occurs in Austin, Texas, with a period of performance from September 1, 2026, through August 31, 2030. The assistance type is a Project Grant.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $1.6m | 8/19/26 |